The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Kurt Salmon US healthcare business

12 Jul 2016 08:20

RNS Number : 9110D
Management Consulting Group PLC
12 July 2016
 

12 July 2016

 

 

Sale of Kurt Salmon US healthcare business

Sale of the non-core healthcare consulting business will allow MCG to focus on

Kurt Salmon's market leading international retail and consumer goods practice

 

MCG today announces that it has entered into an agreement for the sale of the healthcare consulting business of Kurt Salmon in the United States to ECG Management Consultants. The cash consideration payable on completion of the sale is expected to be approximately $12.0 million (equivalent to approximately £9.2 million). A further $1 million of consideration is deferred and contingent on post completion performance.

MCG is expected to receive net cash proceeds, excluding deferred consideration, of approximately $10.4 million (equivalent to approximately £8.0 million) after the deduction of estimated transaction costs of $1.6 million (equivalent to £1.2 million). The net proceeds will be subject to tax. MCG will use the net proceeds after tax for general corporate purposes.

The Kurt Salmon healthcare business provides management consulting services to major hospital groups and healthcare organisations throughout the United States. The profit before tax attributable to the Kurt Salmon healthcare business for the year ended 31 December 2015 was £0.7 million (Group: loss before tax £3.7 million). The gross assets of the Kurt Salmon healthcare business at 31 December 2015 were £4.3m, excluding goodwill.

The Kurt Salmon business which will be retained by MCG following the disposal comprises the international consulting practice focusing on clients in the retail and consumer goods sectors, and currently principally operating in the United States, Canada, the United Kingdom, Germany, Japan and China. Kurt Salmon is an established international brand and a leading management consulting firm addressing clients in the retail and consumer goods sector. The Kurt Salmon business which will be retained by MCG represented approximately 80% of the revenues of the continuing operations of Kurt Salmon as a whole for the year ended 31 December 2015.

The business which is being sold does not generate synergies with the larger retail and consumer goods practice of Kurt Salmon and as part of the MCG group its potential for investment is limited. The disposal provides an opportunity for the Group to concentrate on the retained business of Kurt Salmon, which is wholly focused on clients in the global retail and consumer goods sector, and Alexander Proudfoot. The disposal is subject to customary closing conditions, but is expected to complete by the end of July.

The disposal is expected to generate a one-off IFRS loss before tax of approximately £15 million, principally as a result of the write off of goodwill held in the consolidated balance sheet of the Group which will be allocated to the business being sold. The Group profit and loss account will also include non-recurring expenses relating to the disposal, including in relation to the restructuring of certain non-US healthcare consulting operations which are not part of the sale. The Board believes that the disposal will not be accretive to earnings per share. The disposal will strengthen the financial position of the Group by increasing the level of cash resources available to the remaining businesses.

 

Nick Stagg, Chief Executive, commented:

"The sale of the healthcare practice, which follows the sale of the French and related operations of Kurt Salmon in January 2016, will allow MCG to focus on the Kurt Salmon business serving the retail and consumer goods sector, where it is a market leader, as well as the ongoing recovery in Alexander Proudfoot. MCG is in a strong financial position, debt free, and now well placed to promote profitable growth in its more focused continuing operations."

For further information please contact:

 

Management Consulting Group PLC

Nick Stagg

Chief Executive

020 7710 5000

Chris Povey

Finance Director

020 7710 5000

FTI Consulting

Victoria Foster Mitchell / Ben Atwell

020 3727 1000

  

ECG Management Consultants

Gary K. Edmiston

Chief Executive Officer

858 436 3220

Susan Arnold

Marketing Director

303-841-7774

 

Notes to Editors

Management Consulting Group PLC (MMC.L) provides professional services across a wide range of industries and sectors.

 

It comprises two independently managed practices: Alexander Proudfoot and Kurt Salmon, which both operate worldwide. Alexander Proudfoot helps clients to embed disciplined execution in their operations to achieve growth targets, revenue and profit goals. Kurt Salmon provides consulting services to clients in the retail and consumer goods sector. For further information, visit www.mcgplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUABRNWABARR
Date   Source Headline
21st Apr 20092:00 pmRNSInterim Management Statement
31st Mar 20094:13 pmRNSTotal Voting Rights
30th Mar 20095:48 pmRNSAnnual Report and Accounts
17th Mar 20099:45 amRNSHolding(s) in Company
10th Mar 20094:55 pmRNSDirector/PDMR Shareholding
9th Mar 20097:00 amRNSFinal Results
19th Feb 200912:58 pmRNSHolding(s) in Company
18th Feb 200911:24 amRNSNotice of Results
12th Jan 20095:01 pmRNSHolding(s) in Company
8th Jan 20097:00 amRNSPre-Close Period Trading Update
19th Dec 20084:41 pmRNSSecond Price Monitoring Extn
19th Dec 20084:38 pmRNSPrice Monitoring Extension
12th Dec 20082:23 pmRNSAppointment of Joint Brokers
27th Nov 200810:19 amRNSHolding(s) in Company
13th Nov 20087:00 amRNSInterim Management Statement
22nd Oct 20084:37 pmRNSDirector/PDMR Shareholding
16th Oct 200811:28 amPRNDirector Declaration
9th Oct 20087:00 amRNSBoard Appointment
30th Sep 200810:02 amRNSTotal Voting Rights
29th Aug 20084:57 pmRNSTotal Voting Rights
26th Aug 20083:14 pmRNSDirector/PDMR Shareholding
21st Aug 200810:56 amRNSHolding(s) in Company
18th Aug 200812:21 pmRNSHolding(s) in Company
14th Aug 200810:28 amRNSDirector/PDMR Shareholding
13th Aug 20083:22 pmRNSHolding(s) in Company
11th Aug 20087:00 amRNSInterim Results
31st Jul 20087:43 amRNSTotal Voting Rights
1st Jul 200810:35 amRNSDirector/PDMR Shareholding
30th Jun 20085:04 pmRNSTotal Voting Rights
30th Jun 20088:08 amRNSTrading Update
30th Jun 20088:01 amRNSTrading Update
4th Jun 20085:29 pmRNSPerformance Share Plan
30th May 200812:19 pmRNSTotal Voting Rights
20th May 200812:50 pmRNSDirector/PDMR Shareholding
30th Apr 20083:09 pmRNSTotal Voting Rights
30th Apr 20088:38 amRNSAdditional Listing
23rd Apr 20086:24 pmRNSResult of AGM - Proxy Voting
23rd Apr 200810:46 amRNSNew Organisation/Management
23rd Apr 200810:46 amRNSInterim Management Statement
27th Mar 200811:47 amRNSNotice of AGM
25th Mar 200811:52 amRNSDirectorate Changes
18th Mar 20081:42 pmRNSHolding(s) in Company
18th Mar 20087:01 amRNSFinal Results
6th Mar 20082:21 pmRNSDirectorate Changes
4th Mar 20085:37 pmRNSHolding(s) in Company
25th Feb 20084:36 pmRNSFinal Results - Date Change
25th Feb 20084:14 pmRNSResult of General Meeting
20th Feb 20087:00 amRNSDirectorate Changes
13th Feb 20085:49 pmRNSHolding(s) in Company
1st Feb 200811:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.